API 0.74% $1.35 australian pharmaceutical industries limited

Ann: Retirement of Non-executive Director, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 595 Posts.
    ........intends to retire? And well thanked by the Board.

    Perhaps this little snippet from The Age sheds a bit more light on the "intention to retire". Even once retired, it seems some ex Politicians find it a little tricky to be up front and not spin away like a helicopter's blades........?

    From The Age today:-
    Former health minister Michael Wooldridge has been banned as a company director for more than two years but escaped harsher punishment over his role in collapsed retirement village scheme Prime Trust.
    The penalty was handed down on Tuesday in a judgment against five directors of the failed $500 million scheme.
    Other directors, including founder Bill Lewski, received longer bans, with Mr Lewski's lasting 15 years - the most of any of the scheme's directors.
    The ban handed down to Dr Wooldridge will force him to step down from two ASX-listed boards, including Australian Pharmaceuticals Industries (API), the company that owns Priceline and Soul Pattinson chemist chains, and the Vision Eye Institute.
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.